BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• AxoGen to Host Second Annual Analyst and Investor Day on November 20, 2017

  AxoGen executives and surgeon thought leaders will discuss the company’s comprehensive platform for peripheral nerve repair and the emerging nerve repair market.

  November 7, 2017

   · 

  4 min read
• Business

  Curis Reports Third Quarter 2017 Financial Results

  Management to host conference call today at 8:30 a.m. EST.

  November 7, 2017

   · 

  13 min read
• Business

  Aclaris Therapeutics Reports Third Quarter 2017 Financial Results

  As of September 30, 2017, Aclaris had aggregate cash, cash equivalents and marketable securities of $227.8 million compared to $174.1 million as of December 31, 2016.

  November 7, 2017

   · 

  12 min read
• Business

  Cogentix Medical Reports Third Quarter Results; Second Highest Quarterly Revenue in Company History

  Third quarter revenue was $13.8M, an increase of 3% over the third quarter of 2016.

  November 7, 2017

   · 

  31 min read
• Business

  Kindred Biosciences Announces Third Quarter 2017 Financial Results

  Kindred Biosciences today announced financial results for the third quarter ended September 30, 2017 and provided updates on its programs.

  November 7, 2017

   · 

  11 min read
• Business

  Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results

  Total net product sales from HETLIOZ and Fanapt were $41.3M in the third quarter of 2017, a 2% decrease compared to $42.1M in the second quarter of 2017 and a 7% increase compared to $38.5M in the third quarter of 2016.

  November 7, 2017

   · 

  28 min read
• Business

  Theravance Biopharma Reports Third Quarter 2017 Financial Results and Provides Business Update

  Revenue for the third quarter of 2017 was $4.3M.

  November 7, 2017

   · 

  19 min read
• Business

  Cumberland Pharma Reports 27% Revenue Growth in the Third Quarter

  Cumberland Pharma announced third quarter 2017 financial results with Net Revenues of $11.2M, up 27% over the prior year quarter.

  November 7, 2017

   · 

  33 min read
• Business

  DelMar Pharma Appoints Saiid Zarrabian as Interim Chief Executive Officer

  Mr. Zarrabian is a highly successful industry veteran.

  November 7, 2017

   · 

  5 min read
• Business

  Nektar Therapeutics Reports Financial Results for the Third Quarter of 2017

  Cash and investments in marketable securities at September 30, 2017 were $412.2M as compared to $389.1M at December 31, 2016.

  November 7, 2017

   · 

  26 min read